Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +3.59% slipped 2.87% to $7.10 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.44% rising 0.23% to 4,701.46 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.26% falling 0.03% to 35,804.38. This was the stock's third consecutive day of losses. Ocugen Inc. closed $11.67 short of its 52-week high ($18.77), which the company reached on February 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM -0.36% rose 0.50% to $2.03, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +2.13% rose 3.77% to $6.88, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +1.89% rose 2.01% to $99.88. Trading volume (8.5 M) remained 28.8 million below its 50-day average volume of 37.3 M.